Nevertheless, we can speculate that the nearly 2-fold increase in tumor size between the pre-Cx and Cx stages could have led to the observed linear increase in circulating levels of GDF15, even with a stable production rate at the tumor site, as well as to the strong linear correlation between circulating GDF15 levels and tumor weight (r = 0.8843). This evidence concerns the gene GDF15 and neoplasm.